Form 4 for IMVT Immunovant, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001764013-23-000155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-05 | 2023-12-01 | IMVT | Pande Atul | Dir | S - Sale | $39.73 | -12.3K | 83.2K | -13% | -$490.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 4,129 | $38.80 | 91,379 | D | — | — | (F1) Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person. (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.20 - $39.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. |
| 2 | Common | Common Stock | 2023-12-01 | S | D | 3,374 | $39.82 | 88,005 | D | — | — | (F1) Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person. (F3) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.21 - $40.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. |
| 3 | Common | Common Stock | 2023-12-01 | S | D | 4,847 | $40.46 | 83,158 | D | — | — | (F1) Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person. (F4) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.23 - $40.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. |